Over the past decade, several studies have shown that in stable hemodialysis patients.
esterified to plasma lipids and are presumably cleaved in sis, and 14 controls. Plasma vitamin E concentrations were meavivo by a phospholipase to yield free F 2 -isoprostanes.
sured by high-performance liquid chromatography (HPLC).
Thus, plasma levels of free F 2 -isoprostanes represent the
Results. There was no difference in basal plasma concentrations of F 2 -isoprostanes in the ESRD group prior to hemodialybalance between the formation of esterified F 2 -isoprossis, 246 Ϯ 20 pg/mL, compared to controls, 252 Ϯ 28 pg/mL, or tanes, their subsequent hydrolysis from tissue or plasma immediately on completion of hemodialysis, 236 Ϯ 14 pg/mL. lipids, and metabolism, which may be influenced by coIncubation of control plasma with SIN-1 caused the formation morbid disease [9] [10] [11] . Cardiovascular disease is the most of F 2 -isoprostanes with plasma concentrations increasing to 987 Ϯ 54 pg/mL at 6 hours. The formation of F 2 -isoprostanes important cause of morbidity and mortality in patients stimulated by SIN-1 was markedly enhanced in the plasma with end-stage renal disease (ESRD) [12] , and the susobtained from patients undergoing hemodialysis at 1861 Ϯ 174 ceptibility of plasma lipids to undergo oxidative modifipg/mL, P Ͻ 0.001, and SIN-1-induced formation of F 2 -isoproscation may be an important contributory factor. For extanes was further increased in plasma obtained immediately after hemodialysis at 2437 Ϯ 168 pg/mL, P Ͻ 0.001. Incubation of ample, there is widespread consensus that oxidative plasma with SIN-1 resulted in the net consumption of vitamin E.
modifications of low-density lipoprotein (LDL) within
Conclusion. Although basal plasma F 2 -isoprostanes were simthe arterial wall represent a key early event in the develilar in patients with ESRD compared with controls, the presopment of the atherosclerotic plaque. This hypothesis ence of oxidative stress in patients with ESRD was unmasked is supported by the observation that there is increased when the plasma was stressed by peroxynitrite generated from SIN-1, and this was enhanced further by hemodialysis.
susceptibility of LDL to metal ion-dependent oxidation in vitro in several groups of patients known to be at increased risk of developing atherosclerosis [13] . This addition of copper to LDL suspensions. Typically, LDL oxidation is characterized by a lag phase, followed by  2003 by the International Society of Nephrology propagation of the oxidation reaction [14] . The lag phase, (N ϭ 1). Primary renal diseases were chronic glomerulonephritis (N ϭ 6), glomerulosclerosis (N ϭ 4), chronic which varies in duration with the antioxidant capacity interstitial nephropathy (N ϭ 1), membranoproliferative of LDL, is used as an index of oxidizibility of LDL. The glomerulonephritis (N ϭ 2), diabetic nephropathy (N ϭ lag phase is shortened in patients with chronic renal 1), gouty nephropathy (N ϭ 1), chronic pyelonephritis failure who require regular hemodialysis (ESRD) sug-(N ϭ 3), polycystic kidney disease (N ϭ 2), or no definigesting increased oxidizibility of LDL [15] . This method tive diagnosis possible (N ϭ 3). Of these 23 patients, two is, however, time consuming and does not take into acwere diabetic, eight patients had evidence of cardiovascount the effect of antioxidants in whole plasma. Furthercular, cerebrovascular, or peripheral vascular disease. more, the initiation of oxidation of LDL by metal ions Exclusion criteria were chronic infections, including hepis unlikely to be an important pathway in vivo. Furtheratitis C virus, any preceding acute inflammatory disease, more, the assessment of oxidative stress using other indiand malignancy. No patients were prescribed antioxices has yielded conflicting data [8, [16] [17] [18] . In 1995, we dants such as vitamins C or E, or fibrates. Fourteen reported that the peroxynitrite donor, 3-morpholinohealthy controls age 50 Ϯ 15 years old with no clinical sydnonimine (SIN-1), could cause the oxidation of lipids history or signs of renal disease were recruited from the in whole plasma to form esterified F 2 -isoprostanes. This same local population. No control subjects were taking was in contrast to the inability of copper or myoglobin any antioxidant supplements. All the healthy volunteers to induce oxidation of lipids in whole plasma. It seemed and patients gave informed consent according to the to us that since SIN-1 could cause oxidation of plasma guidelines of the Ethical Committee of the R. Silvestrini lipids that one could assess the oxidizibility of plasma lipids Hospital, Perugia, Italy. by measuring the capacity of plasma components to limit SIN-1-induced formation of F 2 -isoprostanes in whole Sample collection plasma. This technique has the advantage that normal Blood samples were collected into ethylenediamineplasma components, which are removed during the isolatetraacetic acid (EDTA) tubes. Plasma was separated tion of LDL, are still present. This technique might also by centrifugation at 1300g for 20 minutes at 4ЊC. Aliquots allow the efficacy of therapeutic interventions such as of the plasma were transferred to Eppendorf tubes and antioxidant supplementation protocols or the use of vitastored at Ϫ80ЊC until analysis. min-E-coated dialysis membranes to be assessed [19] .
Oxidation of plasma by SIN-1
On the day of study, 1 to 2 mL of plasma was thawed. METHODS SIN-1 (Alexis Ltd., UK) in phosphate-buffered saline Chemicals (PBS) (pH 7.4) was added at 10% of the plasma volume All chemicals were purchased from Sigma (Poole, to give a final concentration of 1 mmol/L SIN-1. Plasma Dorset, UK) unless otherwise stated.
and SIN-1 were incubated at 37ЊC for 0 to 6 hours. Aliquots of plasma were removed (800 L at t ϭ 0, and 200 Subjects L at subsequent time points) during SIN-1 incubation. Twenty-three stable ESRD patients (age, 62 Ϯ 18
Further oxidation of plasma lipids was quenched in the years old; male ϭ 11, female ϭ 12) on regular three removed aliquots by the addition of butylated hydroxytimes a week hemodialyis for more than 6 months were toluene (BHT) 1 mmol/L final concentration and Trolox recruited from the Nephrology and Dialysis Unit of the dissolved in methanol 100 mol/L final concentration. R. Silvestrini Hospital in Perugia, Italy. Patients were well dialyzed (Kt/V Ͼ1.3) using fistula access, with stanExtraction and measurement of F 2 -isoprostanes dard bicarbonate dialysate (AAMI quality) and unfracTotal F 2 -isoprostanes (esterified plus free F 2 -isoprostionated porcine heparin, using either biocompatible or tanes) were quantified by gas chromatography-mass bioincompatible dialysis membranes. The synthetic memspectrometry (GC-MS) after base hydrolysis of lipids in branes comprised polysulphone (Polysulfone Fresenius whole plasma, purification, and derivatization. In brief, A.G., Bad Homburg, Germany) (N ϭ 5), polyamide 1 ng of [
Co., Ann Arbor, MI, USA) were added as internal stanpolymethylmethacrylate (Excebrane Serie Terumo Co., dards to 200 to 800 L of plasma containing BHT. A Japan) (N ϭ 1), and Serie B1 (Toray Co., Japan) (N ϭ 1), half volume of 25% potassium hydroxide was added to or polyacrylonitrile (AN69, Hospal) (N ϭ 1) membranes.
plasma to give a final concentration of 8.3% potassium The cellulosic and/or modified cellulosic membranes comhydroxide and incubated at 37ЊC for 45 minutes. To prised cuprammonium rayon dialyzers (Clirans Terumo extract F 2 -isoprostanes, the pH was adjusted to 3, and the Co., Japan) (N ϭ 8), and cellulose acetate (N ϭ 4), samples were extracted on a tC18 solid-phase extraction cartridge (Waters, UK), converted to the pentafluroor cuprammonium rayon-polyethylenglycol membranes The kinetics of oxidation of plasma lipids obtained peaks over ϳ20 seconds, and quantification is based on before hemodialysis by SIN-1 was studied in 17 out of the the primary peak that coelutes with the deuterated 8-iso-23 patients with ESRD and 13 healthy control subjects. PGF 2␣ internal standard. All results were calculated by Addition of SIN-1 to plasma caused a time-dependent reference to the deuterated 8-iso-PGF 2␣ internal stanincrease in total F 2 -isoprostanes over 6 hours (Fig. 1) . dard. The interassay coefficient of variation of this procePilot studies, in which the formation of total F 2 -isoprosdure is ϳ7%.
tanes was followed up for up to 24 hours, did not show any further increment beyond that observed at 6 hours Measurement of plasma uric acid and (data not shown). Despite the absence of any differences ␣-and ␥-tocopherol in the basal concentration of total F 2 -isoprostanes beUric acid levels (mol/L) were determined by reversetween controls and patients with ESRD, the SIN-1-phase high-performance liquid chromatography (HPLC) induced formation of F 2 -isoprostanes at 6 hours was apcoupled with electrochemical detection [21] . Plasma vitaproximately doubled in ESRD patients (1861 Ϯ 174 min E (␣-and ␥-tocopherol) concentrations were quantipg/mL vs. 987 Ϯ 54 pg/mL; P Ͻ 0.0001) (Fig. 1) . This demfied by HPLC assay [22] . Absolute vitamin E levels were onstrates that plasma lipids from patients with ESRD corrected for plasma triglyceride concentrations (mol/ are more susceptible to oxidation by SIN-1. Having esmmol triglyceride).
tablished the time course for these reactions in vitro, subsequent studies simply compared the concentration Statistical analyses of total F 2 -isoprostanes (at t ϭ 0 hour) to those generated All results are expressed as mean Ϯ SEM. Data was by SIN-1 at 6 hours. analyzed using the Wilcoxon signed-rank test for paired nonparametric data. Multiple comparisons were comEffect of hemodialysis on oxidizibility of plasma lipids pared by analysis of variance (ANOVA). Differences
To assess the effect of dialysis on the oxidizibility of were considered statistically significant if the P value plasma lipids, blood was collected before and within 5 was Ͻ0.05.
minutes of the end of a hemodialysis session, and the SIN-1-induced formation of F 2 -isoprostanes from plasma RESULTS lipids determined at 6 hours in 23 patients with ESRD.
Oxidizibility of plasma lipids in controls and
Following dialysis, the basal concentration of total F 2 -isopatients with ESRD prostanes was 236 Ϯ 14 pg/mL, and this was not significantly different from predialysis concentrations (246 Ϯ The baseline biochemistry and hematology data in the 20 pg/mL). However, the hemodialysis procedure markpatients with ESRD are shown in Table 1 . The concenedly enhanced the SIN-1-induced formation of F 2 -isotration of total F 2 -isoprostanes in plasma taken from the 23 patients with ESRD immediately before a hemodialyprostanes, with peak levels increasing from 1841 Ϯ 166 Fig. 3 . 3-morpholino-sydnonimine (SIN-1) generated levels of F 2 -isoData (mean Ϯ SEM) are expressed as nmol of uric acid or vitamin E prostanes (F 2 -IsoPs) (at 6 hours) in plasma from patients before () consumed per minute. The samples from normal controls (), patients and after ( ) hemodialysis. Dialysis membranes were divided into before dialysis ( ), and patients after dialysis ( ) are shown. ** Signifibiocompatible and bioincompatible. In both groups there was a significantly different from control values (ANOVA, P Ͻ 0.05). cantly enhanced generation of F 2 -isoprostanes by SIN-1 after dialysis compared with predialysis values. ** Significantly different (P Ͻ 0.01) from baseline (prehemodialysis) levels. However, there was no significant difference between the two types of membrane used in this study. determined in a subgroup of four patients before and after hemodialysis and in four healthy controls. Basal uric acid levels were higher in patients with ESRD (361 Ϯ pg/mL to 2437 Ϯ 168 pg/mL; P Ͻ 0.001 (Fig. 2) in the 17 mol/L) compared with healthy controls (210 Ϯ 29 23 subjects studied.
mol/L; P Ͻ 0.01), consistent with a decreased renal Effect of dialysis membrane on the oxidizibility of elimination of uric acid in the ESRD group. Plasma uric plasma lipids acid decreased following hemodialysis (361 Ϯ 17 mol/L to 123 Ϯ 21 mol/L, P Ͻ 0.01). Addition of SIN-1 to The oxidizibility of plasma lipids was compared in the plasma resulted in the net consumption of uric acid, two groups of patients undergoing dialysis with either although there were no differences between the amount synthetic (N ϭ 10) or cellulosic membranes (N ϭ 13).
of uric acid consumed when ESRD and controls or beAs shown in Figure 3 , there was no significant difference fore and after dialysis specimens were compared (Fig. 4A) . between the two types of membranes used (P ϭ NS).
The interpretation of vitamin E (as ␣-tocopherol) conEffect of SIN-1 on plasma urate and centration in plasma is complicated by differences in tocopherol concentrations plasma lipid levels and by the acute hemoconcentration that occurs with plasma solutes that are not filtered durThe effect of SIN-1 oxidation on plasma concentrations of uric acid, as well as ␣-and ␥-tocopherol was ing hemodialysis. Plasma vitamin E levels were signifi-cantly decreased in ESRD patients after correction for tween patients with chronic renal failure and controls led us to develop a new method to assess the oxidizibility triglyceride concentration compared to normal controls, but there was no significant change in vitamin E levels of plasma lipids with SIN-1 in ESRD patients. This method measures oxidative stress under basal conditions in vivo before and after dialysis. The vitamin E concentrations were ESRD, before hemodialysis, 12 Ϯ 2 mol/mmol as determined by basal plasma total F 2 -isoprostanes, and then quantitates the generation of F 2 -isoprostanes in triglyceride; after hemodialysis, 15 Ϯ 2 mol/mmol tryglyceride; and controls, 34 Ϯ 6 mol/mmol triglyceride.
vitro after stressing plasma lipids by the addition of the peroxynitrite generator SIN-1. Following the addition of SIN-1 to plasma there was a time-dependent consumption of vitamin E. This was There was no difference between basal plasma F 2 -isoprostanes in patients with ESRD or controls, and plasma minimal in the plasma of normal controls over the 6-hour incubation with SIN-1 (Fig. 4B) . However, a marked levels did not increase after hemodialysis. This was a surprising observation since it was recently reported in consumption of vitamin E in plasma was observed after 2 hours of incubation with SIN-1. The consumption of a definitive study by Handelman et al [25] that basal esterified F 2 -isoprostanes were increased by ϳsixfold in vitamin E was enhanced further in the plasma of patients immediately following hemodialysis and was consistent patients undergoing regular intermittent hemodialysis [25] , but that a single episode of hemodilaysis did not with increased oxidation of plasma lipids as evidenced in Figure 2 .
significantly enhance the formation of esterified F 2 -isoprostanes. We did, however, observe a significant inThe basal plasma concentration of ␥-tocopherol was 1.4 Ϯ 0.3 mol/L in normal controls and 1.7 Ϯ 0.3 mol/L crease in the oxidizibility of plasma lipids by peroxynitrite in patients with ESRD, and this effect was enhanced and 2.3 Ϯ 0.5 mol/L in patients before and after hemodialysis, respectively. There were no significant changes by hemodialysis. Thus, our data suggest that there is increased consumption of plasma antioxidants, and are in plasma concentrations of ␥-tocopherol during the 6-hour incubation with SIN-1, which remained at over consistent with the presence of oxidative stress in patients with ESRD, which is enhanced by hemodialysis. 90% of its basal levels in both patients and controls (data One alternative possibility is that an altered lipid profile not shown).
in the patients with chronic renal failure could increase the levels of the substrate for SIN-1-induced oxidation, DISCUSSION namely arachidonic acid. However, several studies have The aim of this study was to measure basal oxidative consistently shown that patients with chronic renal failstress in patients with ESRD undergoing hemodialysis ure, including those on hemodialysis, exhibit a signifiand to assess whether hemodialysis causes further oxidacantly lower plasma concentration of arachidonic acid tive injury. At present it is not clear whether the measure- [26] [27] [28] suggesting that this is not the mechanism for ment of free or esterified F 2 -isoprostanes represents the increased F 2 -isoprostane generation by SIN-1. Moreover, best marker for systemic oxidative stress in vivo. Most the observation that the oxidation of plasma lipids was studies have used measurement of free F 2 -isoprostanes enhanced further following hemodialysis is consistent [23, 24] . However, decreased elimination of free F 2 -isowith consumption or depletion of endogenous antioxiprostanes due to chronic renal failure, or enhanced redants. The explanation for the discrepancy between our moval or generation during hemodialysis, makes the asdata, and that published by Handelman et al [25] may sessment of lipid peroxidation in ESRD more difficult.
lie in fundamental differences of clinical practice beIn a pilot study, we measured the plasma concentrations tween the United States and Europe, in terms of vascular of free F 2 -isoprostanes in 26 patients with chronic renal access and the reuse of dialyzers. Many patients in the failure patients who did not require hemodialysis. There study by Handelman et al [25] were dialyzed through was a modest but significant increase in plasma free central venous access catheters and had an elevated F 2 -isoprostanes in patients with chronic renal failure C-reactive protein (CRP), suggesting chronic inflammacompared to controls (chronic renal failure 35 Ϯ 5 pg/mL tion. It is not stated whether the dialysis membranes vs. control 20 Ϯ 2 pg/mL, P Ͻ 0.01). The advantage of were reused, but this is standard practice in many dialysis measuring esterified F 2 -isoprostanes is that the problem units in the United States. In the current study, all paof renal elimination is excluded. However, dynamic tients were dialyzed through native arteriovenous fistuchanges, such as those that may be generated during las, and with single use dialysis membranes, and Eurohemodialysis, may occur too slowly to detect immedipean Pharmacopoiea Standard dialysate water. There ately at the end of the dialysis session, since lipid peroxiare some data to suggest that reusing dialysis membranes dation commences with initiation of oxidation followed may be associated with an increased risk of cardiac morby propagation, and this process takes a few hours in tality, and other studies have shown a strong correlation vitro. Our initial observation that only modest differbetween increased CRP levels and cardiac deaths [29] . Indeed, Handelman et al [25] showed a positive correlaences of plasma-free F 2 -isoprostanes were observed be-tion between CRP levels and basal F 2 -isoprostane conin bioincompatible materials. Free radicals may be generated by leukocyte activation, due to membrane and/or centrations. This suggests that chronic inflammation leads to oxidative stress in ESRD. In the present study, we dialysate interactions, contaminated dialysate, mechanical stress induced by peristaltic pumps, chemical stimuli did not measure the CRP levels at the time of blood collection. However, on reviewing the routine monthly induced by the uremic environment, and abrupt changes in pH and solute concentrations associated with hemodi-CRP data available from 13 of the patients in this study, we observed a median concentration of CRP of 6.5 mg/L alysis [34] . Moreover, during hemodialysis, the release of proinflammatory cytokines and chemotactic factors may (normal range, Ͻ10 mg/L). Both interleukin-6 (IL-6) and tumor necrosis factor-␣ (TNF-␣) were also measured activate leukocytes and the endothelium. Thus, chronic (ELISA) in these patients at around the time when these hemodialysis patients may be at increased risk of free patients were studied. The median concentrations of IL-6 radical-mediated injury. This may be important in the and TNF-␣ were 3.3 pg/mL (normal range, Ͻ 3.1 pg/mL) development and subsequent progression of cardiovasand 15.9 pg/mL (normal range, Ͻ15.6 pg/mL), respeccular complications. In particular, LDL lipids might be at tively. Therefore, the absence of chronic inflammation risk of oxidation when exposed to a high flux of reactive in our patient population may be the major reason why oxygen or nitrogen species as observed in the subendothere was no overt basal oxidative stress in our patient thelium during the genesis of the atherosclerotic plaque. group compared to our controls.
Several groups have been interested in the relative oxidaThe key observation in our present study is that even tive stress imposed by different membranes used in though basal concentrations of total F 2 -isoprostanes in chronic hemodialysis [35] . Although it was not a primary patients with ESRD were not significantly different from aim of this study to compare the effect of different types healthy controls, subtle differences in endogenous deof dialyzer membranes on SIN-1-induced oxidation of fenses against oxidative stress could be revealed by plasma lipids, we were not able to demonstrate any statisstressing the plasma lipids with peroxynitrite, using the tically significant difference between synthetic and celluperoxynitrite generator SIN-1 [30] . One of the key adlosic-based membranes. However, F 2 -isoprostane genervantages of this method is that it evaluates the oxidizibilation was slightly greater, in particular following dialysis, ity of plasma lipids without the need to separate and isoin those patients who used the cellulosic membranes. late LDL, for in vitro studies. In a recent study, Thomas, This study has highlighted a new approach to assess Davies, and Stocker [31] exposed human plasma from the oxidizibility of plasma lipids. In our method we used normal subjects to 5 mmol/L SIN-1 and also observed a the water-soluble SIN-1 because it produces species minimal consumption of ␣-tocopherol and urate over (namely, O
•Ϫ
and NO
• further reacting to form ONOO Ϫ ) the first 6 hours of incubation. In the present study, there that are likely to be important factors in LDL oxidation was an increased consumption of vitamin E, while uric in the subendothelium [36] . Moreover, we chose to assess acid consumption was minimal. Thomas, Davies, and lipid oxidizibility in whole plasma instead of its subfracStocker also observed a rapid consumption of ascorbate, tions since it characterizes the oxidizibility of all plasma bilirubin, and ubiquinol-10. Although plasma ascorbate lipoproteins in their biologic milieu rather than just one concentrations were not measured in the current study, lipoprotein class in a buffer system. The study of the previous investigations have shown that plasma ascoroxidizibility of plasma represents a valid approach to ex bate concentrations in patients with ESRD before hemovivo evaluation of the risk of lipid peroxidation in health dialysis are decreased by about 50% compared to control and disease. This method has wide applicability, is readily values, and this decreases by a further 50% after hemoreproducible, and will help to assess therapeutic strategies dialysis [12] . Other studies have suggested that plasma aimed to prevent lipid peroxidation during hemodialysis concentrations of other antioxidants (such as thiols, seleand the development of cardiovascular disease. nium, glutathione peroxidase, and coenzyme Q 10 ) are also decreased in patients with chronic renal failure because ACKNOWLEDGMENT of increased consumption during oxidative stress. DeWe thank Deborah Hobbs for excellent technical assistance. creased plasma concentrations of vitamin E have been observed in other studies [32] of patients undergoing hemodialysis is more susceptible Email: kmoore@rfc.ucl.ac.uk to oxidation by SIN-1 and this is further enhanced immediately after dialysis. This may be related to removal REFERENCES of low-molecular-weight water-soluble antioxidants by free radicals generated during extracorporeal circulation
